The new buyer will purchase 9 million systems, bringing Mobileye's estimates for future sales to 19 million units. Last March, Mobileye announced that its first customer, Volkswagen Group (XE:VOW3) ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Researchers at Rutgers and Stockton universities are deploying a new research buoy they hope will unlock new economic and ...

BANGKOK, Nov. 19, 2025 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, and Siemens Smart Infrastructure have formalized a global partnership to deliver ...

– Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing – – Phase 2 studies are ongoing to assess the ...

Editor’s note: This is Part 1 of a two-part series on crime solutions from Katie Hill and Jens Ludwig of the University of Chicago Crime Lab. The overheated political moment we’re in has led people to ...

Undercurrent News now provides data licensing, or API access, to our global seafood trade database, an addition to the existing API service on our global and US wholesale seafood price offerings. Data ...

SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...

- Interim data from Phase 1/2a study demonstrate near complete inhibition in hemolytic activity and functional activity of alternative complement pathway “Dysregulated activation of the complement ...